SCHEMBL7075669

SCHEMBL7075669

COc1ccccc1C(=O)Nc1ccc(NC(=O)OC(C)(C)C)cc1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.63
RAB9A P51151 4/20 0.63
ALDH1A1 P00352 2/20 0.63
KCNK3 O14649 5/20 0.61
KCNK9 Q9NPC2 5/20 0.61
SMN1; SMN2 Q16637 3/20 0.60
TP53 P04637 3/20 0.60
NPC1 O15118 3/20 0.60
MAPK1 P28482 2/20 0.60
KMT2A Q03164 5/20 0.59
KDM4E B2RXH2 1/20 0.56
LMNA P02545 1/20 0.56
AHR P35869 1/20 0.56
GFER P55789 1/20 0.56
MEN1 O00255 2/20 0.54
POLB P06746 2/20 0.54
RXFP1 Q9HBX9 1/20 0.53
TSHR P16473 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6816622 0.86 KMT2A (0.50) MAPTRAB9AALDH1A1KCNK3KCNK9
SCHEMBL7328743 0.83 MAPT (0.66) MAPTRAB9AALDH1A1KCNK3KCNK9
SCHEMBL7075336 0.83 HPGD (0.64) MAPTRAB9AALDH1A1KCNK3KCNK9
SCHEMBL6816151 0.83 ALDH1A1 (0.63) ALDH1A1MAPK1KMT2ALMNAGFER
SCHEMBL2721612 0.82 MAPT (0.73) MAPTRAB9AALDH1A1KCNK3KCNK9
SCHEMBL2362772 0.82 KMT2A (0.82) MAPTRAB9AALDH1A1KCNK3KCNK9
SCHEMBL7081264 0.82 MEN1 (0.69) MAPTRAB9AALDH1A1SMN1; SMN2TP53
SCHEMBL7076492 0.82 PTGS1 (0.59) RAB9AALDH1A1SMN1; SMN2NPC1KMT2A
SCHEMBL7719121 0.82 SMO (0.60) MAPTRAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL7076004 0.82 NPC1 (0.63) MAPTRAB9AALDH1A1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030036653-A1 Diaminopyridine-containing thiourea inhibitors of herpes viruses AMERICAN HOME PRODUCTS CORPORATION 2003-02-20 US disclosed
US-20020026055-A1 Aminopyridine-containing thiourea inhibitors of herpes viruses AMERICAN HOME PRODUCTS CORPORATION 2002-02-28 US disclosed
US-20010039348-A1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group AMERICAN HOME PRODUCTS CORPORATION (US) 2001-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036653-A1 Diaminopyridine-containing thiourea inhibitors of herpes viruses HAVCR2, CCR6, CXCR6 MAPT 3898/4885RAB9A 3069/4885ALDH1A1 3447/4885
US-20010039348-A1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group CCR6, HAVCR2, BCOR MAPT 3272/4885RAB9A 3048/4885ALDH1A1 3620/4885
US-20020026055-A1 Aminopyridine-containing thiourea inhibitors of herpes viruses TK1, TPMT, CXCR6 MAPT 4129/4885RAB9A 732/4885ALDH1A1 3601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.